presidents_message.pdf | |
File Size: | 209 kb |
File Type: |
women_in_research.pdf | |
File Size: | 66 kb |
File Type: |
In the press
The Association for Research in Vision and Ophthalmology (ARVO) is one of the largest organisations in both basic and translational eye research. The conference takes place every Spring and attracts about 7000 attendees.
Following Prof. Sarah Coupland's election as Board member in May 2013, Sarah is keen to highlight the importance of women’s career development in science, both on an institutional and international scale.
The current President of ARVO, Dr Justine Smith, is also keen to encourage female progression in vision and eye research- something that is particularly important both to ARVO and the Athena Swan programme at the University of Liverpool.
Following Prof. Sarah Coupland's election as Board member in May 2013, Sarah is keen to highlight the importance of women’s career development in science, both on an institutional and international scale.
The current President of ARVO, Dr Justine Smith, is also keen to encourage female progression in vision and eye research- something that is particularly important both to ARVO and the Athena Swan programme at the University of Liverpool.
Welcome
The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital. Prof. Damato leads the clinical research portfolio of the LOORG and heads the Liverpool Ocular Oncology Centre (LOOC). A major strength of the LOORG is the close collaboration between ocular oncology clinicians, pathologists and basic scientists that ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients. This website is both for patients who wish to know more about the research that is being conducted by the Liverpool Ocular Oncology Group and for researchers who wish to explore the research interests and expertise within the group. |